ARTICLE | Clinical News
PI-88: Completed Phase Ib study
February 5, 2001 8:00 AM UTC
Progen Industries Ltd. (ASX:PGL; PGLAF), Brisbane, Australia Product: PI-88 Business: Cancer Therapeutic category: Angiogenesis Target: Blood vessels Description: Sulfated mannopentaose phosphate Ind...